Published in Antimicrob Agents Chemother on September 30, 2013
Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy. Eur J Clin Pharmacol (2015) 0.78
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy. HIV AIDS (Auckl) (2015) 0.75
A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. JAMA (1965) 7.83
Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse (1987) 3.54
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS (2002) 3.45
Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology (2008) 2.27
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet (2002) 1.96
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). Int J Drug Policy (2007) 1.88
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr (2006) 1.73
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. Chirality (2004) 1.69
Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes. Chem Res Toxicol (1996) 1.39
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet (2008) 1.33
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Opioid substitution and HIV/AIDS treatment and prevention. Lancet (2004) 1.28
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis (2003) 1.28
The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention. Clin Infect Dis (2006) 1.28
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metab Dispos (2003) 1.22
Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation. Basic Clin Pharmacol Toxicol (2010) 1.21
Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. Clin Ther (2002) 1.20
Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy. AIDS Patient Care STDS (2007) 1.20
Clinical pharmacokinetic and pharmacodynamic profile of the HIV integrase inhibitor elvitegravir. Clin Pharmacokinet (2011) 1.19
Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings. Int J Drug Policy (2010) 1.17
Mechanism of efavirenz influence on methadone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (2012) 1.04
Pharmacologic comparison of the optical isomers of methadon. J Pharmacol Exp Ther (1948) 1.03
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. J Clin Psychopharmacol (2002) 0.96
Lack of indinavir effects on methadone disposition despite inhibition of hepatic and intestinal cytochrome P4503A (CYP3A). Anesthesiology (2012) 0.91
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Rev Clin Pharmacol (2013) 0.89
Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction. AIDS (2005) 0.87
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis (2009) 6.81
HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med (2009) 4.76
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet (2010) 3.90
Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet (2007) 3.65
A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci U S A (1996) 3.25
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (2001) 2.84
Effective gating charges per channel in voltage-dependent K+ and Ca2+ channels. J Gen Physiol (1996) 2.77
Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients. J Acquir Immune Defic Syndr (2006) 2.72
In vivo flow cytometer for real-time detection and quantification of circulating cells. Opt Lett (2004) 2.46
Potentiation by the beta subunit of the ratio of the ionic current to the charge movement in the cardiac calcium channel. Science (1993) 2.38
Postdural puncture headache: a randomized comparison of five spinal needles in obstetric patients. Anesth Analg (2000) 2.37
Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis (2007) 2.37
Essential Ca(2+)-binding motif for Ca(2+)-sensitive inactivation of L-type Ca2+ channels. Science (1995) 2.30
Engineering aspects of enzymatic signal transduction: photoreceptors in the retina. Biophys J (2000) 2.24
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Electrocardiographic changes during cesarean section: a cause for concern? Anesth Analg (1993) 2.08
The nuclear matrix: a structural milieu for genomic function. Int Rev Cytol (1995) 2.05
Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology (2002) 2.00
Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother (2001) 1.96
The amino terminus of a calcium channel beta subunit sets rates of channel inactivation independently of the subunit's effect on activation. Neuron (1994) 1.91
Hrs interacts with sorting nexin 1 and regulates degradation of epidermal growth factor receptor. J Biol Chem (2000) 1.91
Evidence that HetR protein is an unusual serine-type protease. Proc Natl Acad Sci U S A (1998) 1.83
Cloning and expression of a third calcium channel beta subunit. J Biol Chem (1993) 1.77
Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci U S A (2009) 1.76
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr (2006) 1.73
Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis (2008) 1.70
Targeting the chromatin-remodeling MSL complex of Drosophila to its sites of action on the X chromosome requires both acetyl transferase and ATPase activities. EMBO J (2000) 1.69
Ca(2+)-dependent inactivation of a cloned cardiac Ca2+ channel alpha 1 subunit (alpha 1C) expressed in Xenopus oocytes. Biophys J (1994) 1.69
Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication. Clin Infect Dis (2004) 1.69
Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med (2002) 1.66
Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acquir Immune Defic Syndr (2006) 1.65
White matter abnormalities in mobility-impaired older persons. Neurology (2000) 1.61
A nuclear matrix protein interacts with the phosphorylated C-terminal domain of RNA polymerase II. Mol Cell Biol (1998) 1.59
Cloning and expression of a neuronal calcium channel beta subunit. J Biol Chem (1993) 1.54
Sexual risk behaviour among HIV-positive individuals in clinical care in urban KwaZulu-Natal, South Africa. AIDS (2006) 1.52
The locomotion, shape and pseudopodial dynamics of unstimulated Dictyostelium cells are not random. J Cell Sci (1993) 1.51
Culture conversion among HIV co-infected multidrug-resistant tuberculosis patients in Tugela Ferry, South Africa. PLoS One (2011) 1.50
Antiviral principles of Propionibacteria-isolation and activity of propionins B and C. Proc Soc Exp Biol Med (1968) 1.48
Effect of epidural analgesia with ambulation on labor duration. Anesthesiology (2001) 1.47
Chorioamnionitis, not epidural analgesia, is associated with maternal fever during labour. Can J Anaesth (2001) 1.46
A rat sciatic nerve model for independent assessment of sensory and motor block induced by local anesthetics. Anesth Analg (1992) 1.40
Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials (2007) 1.39
Molecular analysis and functional expression of the human type E neuronal Ca2+ channel alpha 1 subunit. Receptors Channels (1994) 1.37
Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc Natl Acad Sci U S A (1992) 1.37
Activated macrophages direct apoptosis and suppress mitosis of mesangial cells. J Immunol (2000) 1.34
Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study. J Acquir Immune Defic Syndr (2008) 1.33
Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32
Efficacy of ProTaper Universal rotary retreatment system for gutta-percha removal from root canals. Int Endod J (2007) 1.31
A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. J Acquir Immune Defic Syndr (2012) 1.30
Activation of Indian hedgehog promotes chondrocyte hypertrophy and upregulation of MMP-13 in human osteoarthritic cartilage. Osteoarthritis Cartilage (2012) 1.26
Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers. Antimicrob Agents Chemother (2005) 1.24
Evaluating the effects of providing financial incentives to tuberculosis patients and health providers in China. Int J Tuberc Lung Dis (2008) 1.22
T-type and N-type calcium channels of Xenopus oocytes: evidence for specific interactions with beta subunits. Biophys J (1994) 1.22
Coupling between charge movement and pore opening in vertebrate neuronal alpha 1E calcium channels. J Physiol (1996) 1.19
Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol (2000) 1.19
Optimization of arterial oxygenation during one-lung anesthesia. Anesth Analg (1980) 1.18
Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet (2010) 1.17
A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program. PLoS One (2013) 1.15
Development and assessment of an innovative culturally sensitive educational videotape to improve adherence to highly active antiretroviral therapy in Soweto, South Africa. J Acquir Immune Defic Syndr (2006) 1.15
A proinflammatory role of IL-18 in the development of spontaneous autoimmune disease. J Immunol (2001) 1.14
GPR54 polymorphisms in Chinese girls with central precocious puberty. Neuroendocrinology (2007) 1.08
Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure. Clin Pharmacol Ther (2008) 1.08
Changes in microbial contamination levels of porcine carcasses and fresh pork in slaughterhouses, processing lines, retail outlets, and local markets by commercial distribution. Res Vet Sci (2012) 1.06
Confirmation of the depth of the endotracheal tube by ultrasound. Ultraschall Med (2014) 1.06
Incomplete hypospadiac urethral duplication with posterior urethral valves. Pediatr Surg Int (1998) 1.05
Failed regional anesthesia with reduced spinal bupivacaine dosage in a parturient with achondroplasia presenting for urgent cesarean section. Int J Obstet Anesth (2005) 1.03
Humidity and the anesthetized patient. Anesthesiology (1979) 1.03
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer. Br J Cancer (1998) 1.02
Opioid dependence: rationale for and efficacy of existing and new treatments. Clin Infect Dis (2006) 1.00
Obstetrical lumbar epidural anesthesia in patients with previous posterior spinal fusion for kyphoscoliosis. Anesth Analg (1985) 0.99
Comparison of ropivacaine 0.1%-fentanyl and bupivacaine 0.125%-- fentanyl infusions for epidural labour analgesia. Can J Anaesth (2000) 0.99
Structure of double-shelled rice dwarf virus. J Virol (1998) 0.99
Application of cDNA selection techniques to regions of the human MHC. Genomics (1993) 0.98
Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health (2003) 0.98
The new paradigm: integrating genomic function and nuclear architecture. J Cell Biochem Suppl (1998) 0.97
Minimal diversity of drug-resistant Mycobacterium tuberculosis strains, South Africa. Emerg Infect Dis (2014) 0.97
Bifid mandibular condyle with temporomandibular joint ankylosis: report of two cases and review of literature. Skeletal Radiol (2009) 0.97
Adverse events in an integrated home-based treatment program for MDR-TB and HIV in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2013) 0.97
Facilitation by the beta2a subunit of pore openings in cardiac Ca2+ channels. J Physiol (1998) 0.97
Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett (1994) 0.97
A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice. Proc Natl Acad Sci U S A (1996) 0.96
Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler (2007) 0.96
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study. Biomed Chromatogr (2008) 0.95
Cholinergic stimulation of lacrimal acinar cells promotes redistribution of membrane-associated kinesin and the secretory protein, beta-hexosaminidase, and increases kinesin motor activity. Exp Eye Res (1997) 0.95
Labour analgesia with intrathecal fentanyl decreases maternal stress. Can J Anaesth (1997) 0.95
Dual activation of the cardiac Ca2+ channel alpha 1C-subunit and its modulation by the beta-subunit. Am J Physiol (1995) 0.94
Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa. PLoS One (2013) 0.94
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta. Mult Scler (2005) 0.94
Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa. BMC Infect Dis (2013) 0.94
Identification of the source of the bilateral projection system from cortex to somatosensory neostriatum and an exploration of its physiological actions. Neuroscience (2001) 0.93
Probing the structure of influenza B hemagglutinin using site-directed mutagenesis. Virology (1995) 0.93
IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest Ophthalmol Vis Sci (2001) 0.92
New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine. Antimicrob Agents Chemother (2010) 0.92
Detection of anesthesia machine faults. Anesth Analg (1984) 0.92
Genetically engineered bacteria: electrochemical sensing systems for antimonite and arsenite. Anal Chem (1997) 0.92
Anesthetic considerations in Takayasu arteritis. Anesth Analg (1979) 0.91
AMP-activated kinase mediates adipose stem cell-stimulated neuritogenesis of PC12 cells. Neuroscience (2011) 0.91
Effects of site-specific mutation on structure and activity of influenza virus B/Lee/40 neuraminidase. Virology (1987) 0.91